Matches in Nanopublications for { ?s ?p "[CYP2C19 genetic polymorphism also affects the therapeutic outcome of gastroesophageal reflux disease (GERD), reflux oesophagitis and duodenal ulcers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP256337.RAyQWRjjRduJ_FUFVt4Wuw7ocqET-ZZTjHxr34MvqlqPU130_assertion description "[CYP2C19 genetic polymorphism also affects the therapeutic outcome of gastroesophageal reflux disease (GERD), reflux oesophagitis and duodenal ulcers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256337.RAyQWRjjRduJ_FUFVt4Wuw7ocqET-ZZTjHxr34MvqlqPU130_provenance.
- NP677711.RAsHdnRVkDGwzed4IQlL-g_Ceocfrp5B3gdbxwfN04eFE130_assertion description "[CYP2C19 genetic polymorphism also affects the therapeutic outcome of gastroesophageal reflux disease (GERD), reflux oesophagitis and duodenal ulcers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP677711.RAsHdnRVkDGwzed4IQlL-g_Ceocfrp5B3gdbxwfN04eFE130_provenance.
- NP680590.RAj-3068d2tEl9rwcsYjkD0XAV4b0JVfCRgdgfDr6PiIU130_assertion description "[CYP2C19 genetic polymorphism also affects the therapeutic outcome of gastroesophageal reflux disease (GERD), reflux oesophagitis and duodenal ulcers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680590.RAj-3068d2tEl9rwcsYjkD0XAV4b0JVfCRgdgfDr6PiIU130_provenance.
- NP490503.RA4c8T9xFOhVyKJOFusQc0o_Vo5Z1Q-qJwRC-yybwLiVo130_assertion description "[CYP2C19 genetic polymorphism also affects the therapeutic outcome of gastroesophageal reflux disease (GERD), reflux oesophagitis and duodenal ulcers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP490503.RA4c8T9xFOhVyKJOFusQc0o_Vo5Z1Q-qJwRC-yybwLiVo130_provenance.
- NP691137.RAqh8KzH1Lh4jRs5D8mevkQKN_GmOJTCFSHcBIzaUVQ2Q130_assertion description "[CYP2C19 genetic polymorphism also affects the therapeutic outcome of gastroesophageal reflux disease (GERD), reflux oesophagitis and duodenal ulcers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691137.RAqh8KzH1Lh4jRs5D8mevkQKN_GmOJTCFSHcBIzaUVQ2Q130_provenance.
- NP341551.RA6JppuyPYAJC5YjkACuEz68QL3r_ivCy9oFiedd8NG80130_assertion description "[CYP2C19 genetic polymorphism also affects the therapeutic outcome of gastroesophageal reflux disease (GERD), reflux oesophagitis and duodenal ulcers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341551.RA6JppuyPYAJC5YjkACuEz68QL3r_ivCy9oFiedd8NG80130_provenance.
- NP341514.RAK98ZqWdRBK2IsJaaKfHvKnl0M0UCHybiH_DOIBxr5DY130_assertion description "[CYP2C19 genetic polymorphism also affects the therapeutic outcome of gastroesophageal reflux disease (GERD), reflux oesophagitis and duodenal ulcers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341514.RAK98ZqWdRBK2IsJaaKfHvKnl0M0UCHybiH_DOIBxr5DY130_provenance.
- NP691138.RAGPvKGldrBTpWM6lMQwurEQcreE4ySEFqWZEl0VyJRn4130_assertion description "[CYP2C19 genetic polymorphism also affects the therapeutic outcome of gastroesophageal reflux disease (GERD), reflux oesophagitis and duodenal ulcers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691138.RAGPvKGldrBTpWM6lMQwurEQcreE4ySEFqWZEl0VyJRn4130_provenance.